Entegris Inc 10-Q for FY2026 Q3
Entegris Inc (ENTG)
10-Q
2026-10-29
For: 2026-09-26
View Original
Added on
October 29, 2026
About this 10-Q
Entegris Inc filed this 10-Q on October 29, 2026, covering the quarter ended September 26, 2026 (FY2026 Q3).
Entegris reported third-quarter net sales of $1,005.7 million, up 24.6%, and net income of $157.8 million, or $1.03 per diluted share. It expects 2026 depreciation expense to be reduced by approximately $73.0 million after extending certain asset useful lives. AI summary
Headline figures
Quarter ended September 26, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $1.01B
- up 24.6% from $807.1M a year earlier
- Net income
- $157.8M
- up 123.8% from net income of $70.5M a year earlier
- Diluted EPS
- $1.03
- up 123.9% from $0.46 a year earlier
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
____________________________________________
FORM 10-Q
______________________________________________
(Mark One)
| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |||||
For the quarterly period ended September 26, 2026
OR
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |||||
For the transition period from to
Commission file number: 001-32598
 | ||
_______________________________________
(Exact name of registrant as specified in its charter)
_________________________________________
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||||||||
| (Address of principal executive offices) | (Zip Code) | |||||||||||||
(978 ) 436-6500
(Registrant’s telephone number, including area code)
None
(Former name, former address and former fiscal year, if changed since last report)
_______________________________________
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ý No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| ý | Accelerated filer | ☐ | |||||||||||||||
| Non-accelerated filer | ¨ | Smaller reporting company | |||||||||||||||
| Emerging growth company | |||||||||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ý
As of October 26, 2026, there were 152.8 million shares of the registrant’s common stock outstanding.
ENTEGRIS, INC. AND SUBSIDIARIES
FORM 10-Q
TABLE OF CONTENTS
FOR THE QUARTER ENDED September 26, 2026
| Description | Page | ||||
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds | |||||
2
Cautionary Statements
This Quarterly Report on Form 10-Q (this “Quarterly Report”) contains “forward-looking statements”. The words “believe,” “expect,” “anticipate,” “intend,” “estimate,” “forecast,” “project,” “should,” “may,” “will,” “would” or the negative thereof and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are based on current management expectations and assumptions only as of the date of this Quarterly Report. They are not guarantees of future performance and they involve substantial risks and uncertainties that are difficult to predict and that could cause actual results to differ materially from the results expressed in, or implied by, these forward-looking statements. Some factors that could cause actual results to differ include, but are not limited to the risks below:
Risks Related to Our Business and Industry
•Fluctuations in demand for semiconductors and volume of semiconductor manufacturing.
•Global economic uncertainty, including volatile financial markets, inflation and increased costs, trade wars, fluctuations in interest rates, economic recessions, and national debt and bank failures.
•Supply chain risks, including partial reliance on sole, single or limited source suppliers.
•Challenges inherent in operating a global business, including managing complex political, legal, regulatory, and operational environments across the jurisdictions in which the Company operates.
•The impact of export controls, economic sanctions and other similar restrictions.
•Customer concentration.
•The need for continuing innovation and introduction of new products.
•Manufacturing interruptions or delays and other operational disruptions.
•Information technology (“IT”) system failures, network disruptions, data breaches, and other cybersecurity threats.
•The impact of tariffs and a volatile trade environment.
•The use of hazardous materials in our operations.
•Goodwill impairment.
•Loss of key employees.
•Our ability to obtain, protect, and enforce intellectual property rights.
•Our use, and our competitors’ use, of AI
•Environmental, social, and governance commitments.
Risks Related to Government Regulation
•The impact of being subject to numerous rapidly evolving environmental laws and regulations across many jurisdictions.
•Risks related to the regulatory environment, including compliance costs and being subject to potentially inconsistent or conflicting regulations.
•Changes in taxation or adverse tax rulings.
•The impact of government incentives, including added operational complexity and competition.
Risks Related to Our Indebtedness
•The impact of our indebtedness, including our ability to obtain future financing.
•Risks related to our ability to generate sufficient cash to service our indebtedness.
•Restrictions on our operations as a result of the terms of the Amended Credit Agreement (as defined below) and the Indentures (as defined below).
Risks Related to Owning Our Common Stock
•The volatility of the price of our common stock.
•Changes in capital allocation strategy.
•Provisions in our charter documents and Delaware law may delay or prevent us from being acquired.
General Risks
•Significant competition.
•Our ability to successfully acquire or integrate other businesses, form joint ventures, or divest businesses.
•The impact of climate change, including changes in market dynamics and stakeholder expectations, and unexpected operational disruptions.
3
Other Risks
•The other factors and additional information described in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the Securities and Exchange Commission (the “SEC”) on February 11, 2026, including under the heading “Risk Factors” in Part I, Item 1A, and in the Company’s other periodic filings with the SEC.
Except as required under the federal securities laws and the rules and regulations of the SEC, the Company undertakes no obligation to update any forward-looking statements or information contained herein, which speak as of their respective dates.
4
PART 1. FINANCIAL INFORMATION
Item 1. Financial Statements
ENTEGRIS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
| (In millions, except per share data) | September 26, 2026 | December 31, 2025 | |||||||||
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | $ | |||||||||
Trade accounts receivable, net of allowance for credit losses of $ | |||||||||||
| Inventories, net | |||||||||||
| Deferred tax charges and refundable income taxes | |||||||||||
| Other current assets | |||||||||||
| Total current assets | |||||||||||
Property, plant and equipment, net of accumulated depreciation of $ | |||||||||||
| Right-of-use assets | |||||||||||
| Goodwill | |||||||||||
Intangible assets, net of accumulated amortization of $ | |||||||||||
| Deferred tax assets and other noncurrent tax assets | |||||||||||
| Other noncurrent assets | |||||||||||
| Total assets | $ | $ | |||||||||
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ | $ | |||||||||
| Accrued payroll and related benefits | |||||||||||
| Accrued interest payable | |||||||||||
| Other accrued liabilities | |||||||||||
| Income taxes payable | |||||||||||
| Total current liabilities | |||||||||||
Long-term debt, net of unamortized discount and debt issuance costs of $ | |||||||||||
| Pension benefit obligations and other liabilities | |||||||||||
| Deferred tax liabilities and other noncurrent tax liabilities | |||||||||||
| Long-term lease liabilities | |||||||||||
| Equity: | |||||||||||
Preferred stock, par value $ | |||||||||||
Common stock, par value $ | |||||||||||
Treasury stock, at cost: | ( | ( | |||||||||
| Additional paid-in capital | |||||||||||
| Retained earnings | |||||||||||
| Accumulated other comprehensive loss | ( | ( | |||||||||
| Total equity | |||||||||||
| Total liabilities and equity | $ | $ | |||||||||
See the accompanying notes to condensed consolidated financial statements.
5
ENTEGRIS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
| Three months ended | Nine months ended | ||||||||||||||||||||||
| (In millions, except per share data) | September 26, 2026 | September 27, 2025 | September 26, 2026 | September 27, 2025 | |||||||||||||||||||
| Net sales | $ | $ | $ | $ | |||||||||||||||||||
| Cost of sales | |||||||||||||||||||||||
| Gross profit | |||||||||||||||||||||||
| Selling, general and administrative expenses | |||||||||||||||||||||||
| Engineering, research and development expenses | |||||||||||||||||||||||
| Amortization of intangible assets | |||||||||||||||||||||||
| Operating income | |||||||||||||||||||||||
| Interest expense | |||||||||||||||||||||||
| Interest income | ( | ( | ( | ( | |||||||||||||||||||
| Other expense, net | |||||||||||||||||||||||
| Income before income tax expense | |||||||||||||||||||||||
| Income tax expense | |||||||||||||||||||||||
| Equity in net loss of affiliates | |||||||||||||||||||||||
| Net income | $ | $ | $ | $ | |||||||||||||||||||
| Basic earnings per common share | $ | $ | $ | $ | |||||||||||||||||||
| Diluted earnings per common share | $ | $ | $ | $ | |||||||||||||||||||
| Weighted average shares outstanding: | |||||||||||||||||||||||
| Basic | |||||||||||||||||||||||
| Diluted | |||||||||||||||||||||||
See the accompanying notes to condensed consolidated financial statements.
6
ENTEGRIS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
| Three months ended | Nine months ended | ||||||||||||||||||||||
| (In millions) | September 26, 2026 | September 27, 2025 | September 26, 2026 | September 27, 2025 | |||||||||||||||||||
| Net income | $ | $ | $ | $ | |||||||||||||||||||
| Other comprehensive income (loss), net of tax: | |||||||||||||||||||||||
| Foreign currency translation adjustments | ( | ||||||||||||||||||||||
| Defined benefit pension adjustments | ( | ||||||||||||||||||||||
Interest rate swap - cash flow hedge, change in fair value - loss, net of tax benefit of $ | ( | ( | |||||||||||||||||||||
| Other comprehensive income (loss), net of tax | ( | ||||||||||||||||||||||
| Comprehensive income | $ | $ | $ | $ | |||||||||||||||||||
See the accompanying notes to condensed consolidated financial statements.
7
ENTEGRIS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY
(Unaudited)
| (In millions, except per share data) | Common shares issued | Treasury shares | Common shares outstanding | Common stock | Treasury stock | Additional paid-in capital | Retained earnings | Foreign currency translation adjustments | Defined benefit pension adjustments | Interest rate swap - cash flow hedge | Total | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance at December 31, 2024 | ( | $ | $ | ( | $ | $ | $ | ( | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares issued under stock plans | — | — | — | ( | — | — | — | — | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation expense | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividends declared ($ | — | — | — | — | — | — | ( | — | — | — | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest rate swap - cash flow hedge | — | — | — | — | — | — | — | — | — | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pension liability adjustment | — | — | — | — | — | — | — | — | ( | — | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency translation | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net income | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance at March 29, 2025 | ( | $ | $ | ( | $ | $ | $ | ( | $ | ( | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares issued under stock plans | — | — | — | ( | — | — | — | — | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation expense | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividends declared ($ | — | — | — | — | — | — | ( | — | — | — | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest rate swap - cash flow hedge | — | — | — | — | — | — | — | — | — | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency translation | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net income | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance at June 28, 2025 | ( | $ | $ | ( | $ | $ | $ | ( | $ | ( | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares issued under stock plans | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation expense | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividends declared ($ | — | — | — | — | — | — | ( | — | — | — | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest rate swap - cash flow hedge | — | — | — | — | — | — | — | — | — | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency translation | — | — | — | — | — | — | — | ( | — | — | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net income | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance at September 27, 2025 | ( | $ | $ | ( | $ | $ | $ | ( | $ | ( | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||||||||||
8
| (In millions, except per share data) | Common shares issued | Treasury shares | Common shares outstanding | Common stock | Treasury stock | Additional paid-in capital | Retained earnings | Foreign currency translation adjustments | Defined benefit pension adjustments | Interest rate swap - cash flow hedge | Total | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance at December 31, 2025 | ( | $ | $ | ( | $ | $ | $ | ( | $ | ( | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares issued under stock plans | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation expense | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividends declared ($ | — | — | — | — | — | — | ( | — | — | — | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency translation | — | — | — | — | — | — | — | ( | — | — | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net income | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance at March 28, 2026 | ( | $ | $ | ( | $ | $ | $ | ( | $ | ( | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares issued under stock plans | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation expense | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividends declared ($ | — | — | — | — | — | — | ( | — | — | — | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency translation | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net income | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance at June 27, 2026 | ( | $ | $ | ( | $ | $ | $ | ( | $ | ( | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares issued under stock plans | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation expense | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividends declared ($ | — | — | — | — | — | — | ( | — | — | — | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency translation | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net income | — | — | — | — | — | — | — | — | — | $ | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance at September 26, 2026 | ( | $ | $ | ( | $ | $ | $ | ( | $ | ( | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||||||||||
9
ENTEGRIS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
| Nine months ended | |||||||||||
| (In millions) | September 26, 2026 | September 27, 2025 | |||||||||
| Operating activities: | |||||||||||
| Net income | $ | $ | |||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Depreciation | |||||||||||
| Amortization | |||||||||||
| Share-based compensation expense | |||||||||||
| Provision for deferred income taxes | ( | ( | |||||||||
| Loss on extinguishment of debt | |||||||||||
| Charge for excess and obsolete inventory | |||||||||||
Impairment of long-lived assets | |||||||||||
| Amortization of debt issuance costs and original issuance discounts | |||||||||||
| Other | |||||||||||
| Changes in operating assets and liabilities: | |||||||||||
| Trade accounts receivable | ( | ||||||||||
| Inventories | ( | ( | |||||||||
| Accounts payable and accrued liabilities | |||||||||||
| Other current assets | |||||||||||
| Income taxes payable and refundable income taxes | ( | ( | |||||||||
| Other | |||||||||||
| Net cash provided by operating activities | |||||||||||
| Investing activities: | |||||||||||
| Acquisition of property, plant and equipment | ( | ( | |||||||||
| Proceeds from government incentives | |||||||||||
| Other | ( | ( | |||||||||
| Net cash used in investing activities | ( | ( | |||||||||
| Financing activities: | |||||||||||
| Proceeds from revolving credit facility | |||||||||||
| Payments of revolving credit facility | ( | ( | |||||||||
| Payments of long-term debt | ( | ( | |||||||||
| Payments for debt issuance costs | ( | ||||||||||
| Payments for dividends | ( | ( | |||||||||
| Proceeds from issuance of common stock | |||||||||||
| Taxes paid related to net share settlement of equity awards | ( | ( | |||||||||
| Other | ( | ( | |||||||||
| Net cash used in financing activities | ( | ( | |||||||||
| Effect of exchange rate changes on cash and cash equivalents | |||||||||||
| (Decrease) increase in cash and cash equivalents | ( | ||||||||||
| Cash and cash equivalents at beginning of period | |||||||||||
| Cash and cash equivalents at end of period | $ | $ | |||||||||
See the accompanying notes to condensed consolidated financial statements.
10
ENTEGRIS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)
(Unaudited)
| Supplemental Cash Flow Information | Nine months ended | ||||||||||
| (In millions) | September 26, 2026 | September 27, 2025 | |||||||||
| Non-cash transactions: | |||||||||||
| Equipment purchases in accounts payable | $ | $ | |||||||||
| Share issuance in exchange for extinguishment of Employee Stock Purchase Plan liability | |||||||||||
| Schedule of interest and income taxes paid: | |||||||||||
| Interest paid, net of capitalized interest | |||||||||||
| Income taxes paid, net of refunds received | |||||||||||
See the accompanying notes to condensed consolidated financial statements.
11
ENTEGRIS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Nature of Operations Entegris, Inc. (“Entegris”, the “Company”, “us”, “we”, or “our”) is a leading supplier of critical advanced materials and process solutions for the semiconductor and other high-technology industries.
Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. Intercompany profits, transactions and balances have been eliminated in consolidation.
Use of Estimates The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, particularly receivables, inventories, property, plant and equipment, right-of-use assets, goodwill, intangibles, accrued expenses, short-term and long-term lease liabilities, income taxes and related accounts, and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of net sales and expenses during the reporting period. Actual results could differ from those estimates.
Basis of Presentation The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States and contain all adjustments considered necessary, and are of a normal recurring nature, to present fairly the Company’s financial position as of September 26, 2026 and December 31, 2025, the results of operations and comprehensive income for the three and nine months ended September 26, 2026 and September 27, 2025, the equity statements as of and for the three and nine months ended September 26, 2026 and September 27, 2025, and cash flows for the nine months ended September 26, 2026 and September 27, 2025.
The condensed consolidated financial statements and accompanying notes are presented as permitted by Form 10-Q and do not contain certain information included in the Company’s annual consolidated financial statements and notes. The information included in this Quarterly Report should be read in conjunction with Part II, Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025. The results of operations for the three and nine months ended September 26, 2026 are not necessarily indicative of the results to be expected for the full year.
The unit captions to certain tables in the Notes to Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 referenced amounts in thousands. Such amounts are in millions, consistent with the Company’s narrative presentation of its financial results elsewhere in that report. The underlying amounts are unchanged, and no revision to any reported balance, result, or cash flow is necessary. Prior-period amounts presented herein are shown in millions.
Property, Plant and Equipment Property, plant and equipment are carried at cost and are depreciated using the straight-line method over their estimated useful lives. When assets are retired or disposed of, the cost and related accumulated depreciation are removed from the accounts, and any resulting gain or loss is recognized in the period incurred. Maintenance and repairs are expensed as incurred, while significant additions and improvements are capitalized. Long-lived assets, including property, plant and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or group of assets may not be recoverable based on estimated future undiscounted cash flows. The amount of impairment, if any, is measured as the difference between the net book value and the estimated fair value of the asset(s).
In January 2026, we completed an assessment of the useful lives of our property, plant and equipment and adjusted the estimated useful lives of certain property, plant and equipment to more closely reflect the expected economic lives of these assets. These adjustments followed an analysis of our actual usage of assets, including the technological and physical obsolescence of these assets, our ability to continue to use equipment, historical usage trends, and anticipated capital plans and technology roadmaps, as well as industry trends and practices. Based on this analysis, we determined that the increase in useful lives was warranted and consistent with the Company’s historical and anticipated use of these assets. The updated estimated useful lives of certain assets for financial reporting purposes are as follows: buildings and improvements, 5 to 35 years increased to 12 to 40 years; manufacturing equipment, 5 to 10 years increased to 14 years; canisters and cylinders, 3 to 12 years increased to 3 to 19 years; molds, 3 to 5 years increased to 9 years and lab equipment, 3 to 8 years increased to 9 years. The effect of this change in estimate on assets in service as of December 31, 2025 during the three and nine months ended September 26, 2026 was a reduction in depreciation expense of $17.9 million and $55.6 million, respectively, and an increase in net income of approximately $14.8 million and $38.1 million, or $0.10 and $0.25 per basic and $0.10 and $0.25 per diluted share, respectively.
12
Recently Adopted Accounting Pronouncements The Company currently has no material recently adopted accounting pronouncements.
Recently Issued Accounting Pronouncements In November 2024, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires public companies to disclose, in interim and annual reporting periods, additional information about certain expenses in the notes to financial statements. Prospective or retrospective application of the amendments in this ASU is permitted. The updated standard is effective for our annual reporting periods beginning in fiscal year 2027 and interim reporting periods beginning in the first quarter of fiscal year 2028, with early adoption permitted. We are currently evaluating the impact of this ASU on our consolidated financial statements and related disclosures.
In December 2025, the FASB issued ASU No. 2025-10, Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities (“ASU 2025-10”), which establishes authoritative guidance on the recognition, measurement, presentation and disclosure of government grants received by business entities. The amendments in ASU 2025-10 are effective for annual reporting periods beginning after December 15, 2028, and interim reporting periods within those annual reporting periods, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2025-10 but does not expect ASU 2025-10 adoption to have a material impact on its consolidated financial statements.
2. REVENUES
The following table provides information about disaggregated net sales by customer category:
| Three months ended | Nine months ended | ||||||||||||||||||||||
| (In millions) | September 26, 2026 | September 27, 2025 | September 26, 2026 | September 27, 2025 | |||||||||||||||||||
| Semiconductor: | |||||||||||||||||||||||
| Fabs | $ | $ | $ | $ | |||||||||||||||||||
| Equipment and Engineering | |||||||||||||||||||||||
| Chemical and Materials | |||||||||||||||||||||||
| Semi Distributor and Other | |||||||||||||||||||||||
| Non-Semi | |||||||||||||||||||||||
| Total net sales | $ | $ | $ | $ | |||||||||||||||||||
The following table provides information about current contract liabilities from contracts with customers. The contract liabilities are included in Other accrued liabilities in the condensed consolidated balance sheets.
| (In millions) | September 26, 2026 | September 27, 2025 | |||||||||
| Balance at beginning of year | $ | $ | |||||||||
| Revenue recognized that was included in the contract liability balance at the beginning of the period | ( | ( | |||||||||
Increases due to cash received, excluding amounts recognized as revenue during the period | |||||||||||
| Balance at end of period | $ | $ | |||||||||
13
3. INVENTORIES
Inventories consisted of the following:
| (In millions) | September 26, 2026 | December 31, 2025 | |||||||||
| Raw materials | $ | $ | |||||||||
| Work-in-process | |||||||||||
Finished goods (1) | |||||||||||
| Total inventories, net | $ | $ | |||||||||
(1) Includes consignment inventories held by customers of $30.0 million and $25.1 million at September 26, 2026 and December 31, 2025, respectively.
4. GOODWILL AND INTANGIBLE ASSETS
Goodwill activity for each of the Company’s reportable segments, Materials Solutions (“MS”) and Advanced Purity Solutions (“APS”), was as follows at September 26, 2026 and December 31, 2025:
| (In millions) | MS | APS | Total | ||||||||||||||||||||
| December 31, 2025 | $ | $ | $ | ||||||||||||||||||||
| Foreign currency translation | |||||||||||||||||||||||
| September 26, 2026 | $ | $ | $ | ||||||||||||||||||||
Identifiable intangible assets at September 26, 2026 and December 31, 2025 consisted of the following:
| September 26, 2026 | |||||||||||||||||
| (In millions) | Gross carrying amount | Accumulated amortization | Net carrying value | ||||||||||||||
| Developed technology | $ | $ | $ | ||||||||||||||
| Trademarks and trade names | |||||||||||||||||
| Customer relationships | |||||||||||||||||
Other (1) | |||||||||||||||||
| $ | $ | $ | |||||||||||||||
(1) As part of its periodic review of intangible asset records, the Company eliminated certain fully amortized intangible assets from the gross carrying amount and accumulated amortization balances. Gross carrying amounts and related accumulated amortization of approximately $7.5 million were removed, with no impact on net intangible assets, earnings, or cash flows.
| December 31, 2025 | |||||||||||||||||
| (In millions) | Gross carrying amount | Accumulated amortization | Net carrying value | ||||||||||||||
| Developed technology | $ | $ | $ | ||||||||||||||
| Trademarks and trade names | |||||||||||||||||
| Customer relationships | |||||||||||||||||
| Other | |||||||||||||||||
| $ | $ | $ | |||||||||||||||
Future amortization expense relating to intangible assets currently recorded in the Company’s condensed consolidated balance sheets is estimated to be the following at September 26, 2026:
| (In millions) | Remaining 2026 | 2027 | 2028 | 2029 | 2030 | Thereafter | Total | ||||||||||||||||||||||||||||||||||
| Future amortization expense | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
14
5. DEBT
The Company’s debt as of September 26, 2026 and December 31, 2025 consisted of the following:
| (In millions) | September 26, 2026 | December 31, 2025 | |||||||||
| Term Loans B due 2029 | $ | $ | |||||||||
Secured Notes due 2029 at | |||||||||||
Senior Notes due 2030 at | |||||||||||
Senior Notes due 2029 at | |||||||||||
Senior Notes due 2028 at | |||||||||||
Revolving Credit Facility due 2031 (1) | |||||||||||
| Total debt (par value) | |||||||||||
| Less: Unamortized discount and debt issuance costs | ( | ( | |||||||||
| Total debt, net | $ | $ | |||||||||
Annual maturities of long-term debt, excluding unamortized discount and debt issuance costs, due as of September 26, 2026 were as follows:
| (In millions) | Remaining 2026 | 2027 | 2028 | 2029 | 2030 | Thereafter | Total | ||||||||||||||||||||||||||||||||||
| Long-term debt obligation maturities | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
(1) Our senior secured revolving credit facility due 2031 (the “Revolving Credit Facility”) bears interest at a rate per annum equal to, at the Company’s option, either (i) SOFR plus an applicable margin of 1.25 %, 1.5 % or 1.75 % or (ii) a base rate plus an applicable margin of 0.25 %, 0.5 % or 0.75 %, in each case depending on the Company’s first lien net leverage ratio. As of September 26, 2026, the applicable margins were 1.25 % and 0.25 %, respectively. During the three and nine months ended September 26, 2026, the Company borrowed and repaid zero 65.0 750.0 million as of September 26, 2026. There were no
During the three and nine months ended September 26, 2026, the Company repaid a total of $200.0 million and $450.0 million, respectively, of the outstanding borrowings under the Term Loans B. As of September 26, 2026, all outstanding borrowings under the Term Loans B had been fully repaid. In connection with these repayments, the Company incurred a pre-tax loss on extinguishment of debt of $1.7 million and $3.9 million for the three and nine months ended September 26, 2026, which is included in Other expense, net in the condensed consolidated statements of operations.
On April 29, 2026, the Company amended the Revolving Credit Facility to provide for, among other things, lending commitments in an aggregate principal amount of up to $750.0 million, up from $575.0 million, and to extend the maturity to April 29, 2031 from July 6, 2027, and to revise the applicable interest rate margins, commitment fees and certain negative covenants.
The Company is required to record certain assets and liabilities at fair value. The valuation methods used for determining the fair value of these financial instruments by hierarchy are as follows:
Level 1: Assets consist of cash and cash equivalents, including investments in institutional money market funds, and investments in mutual funds. Institutional money market funds and mutual funds are valued using quoted prices in active markets for identical assets. Cash held in various bank accounts to support the Company's operations is carried at cost, which approximates fair value due to its short-term nature.
Level 2 There were no Level 2 financial instruments.
Level 3 There were no Level 3 financial instruments.
The following table presents financial instruments, other than debt, that we measure at fair value on a recurring basis. See Note 5 to our condensed consolidated financial statements for a discussion of our debt. In instances where the inputs used to measure the fair value of an asset fall into more than one level of the hierarchy, we have classified it based on the lowest level input that is significant to the determination of the fair value.
15
| Fair Value Measurements at Reporting Date Using | |||||||||||||||||||||||||||||||||||
| (In millions) | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||||||||
| Assets: | September 26, 2026 | December 31, 2025 | September 26, 2026 | December 31, 2025 | September 26, 2026 | December 31, 2025 | September 26, 2026 | December 31, 2025 | |||||||||||||||||||||||||||
| Cash and cash equivalents | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
Mutual fund investment (1) | |||||||||||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
(1) The mutual fund investment is shown as a component of other noncurrent assets on the condensed consolidated balance sheet.
Other Fair Value Disclosures
The estimated fair value and carrying value of our debt as of September 26, 2026 and December 31, 2025 were as follows:
| September 26, 2026 | December 31, 2025 | |||||||||||||||||||
| (In millions) | Carrying Value | Fair Value | Carrying Value | Fair Value | ||||||||||||||||
| Total debt, net | $ | $ | $ | $ | ||||||||||||||||
7. EARNINGS PER COMMON SHARE
Basic earnings per common share (“EPS”) is calculated based on the weighted average number of shares of common stock outstanding during the applicable period. Diluted EPS is calculated based on the weighted average number of shares of common stock outstanding plus potentially dilutive shares of common stock outstanding during the applicable period. The following table presents a reconciliation of the share amounts used in the computation of basic and diluted EPS:
| Three months ended | Nine months ended | ||||||||||||||||||||||
| (In millions) | September 26, 2026 | September 27, 2025 | September 26, 2026 | September 27, 2025 | |||||||||||||||||||
| Basic—weighted average common shares outstanding | |||||||||||||||||||||||
| Weighted average common shares assumed upon exercise of stock options and vesting of restricted common stock | |||||||||||||||||||||||
| Diluted—weighted average common shares and common shares equivalent outstanding | |||||||||||||||||||||||
The Company excluded the following shares underlying stock-based awards from the calculations of diluted EPS because their inclusion would have been anti-dilutive for the three and nine months ended September 26, 2026 and September 27, 2025:
| Three months ended | Nine months ended | ||||||||||||||||||||||
| (In millions) | September 26, 2026 | September 27, 2025 | September 26, 2026 | September 27, 2025 | |||||||||||||||||||
| Shares excluded from calculations of diluted EPS | |||||||||||||||||||||||
16
8. OTHER EXPENSE, NET
Other expense (income), net for the three and nine months ended September 26, 2026 and September 27, 2025 consisted of the following:
| Three months ended | Nine months ended | ||||||||||||||||||||||
| (In millions) | September 26, 2026 | September 27, 2025 | September 26, 2026 | September 27, 2025 | |||||||||||||||||||
| (Gain) loss on foreign currency transactions | $ | ( | $ | ( | |||||||||||||||||||
| Loss on extinguishment of debt | |||||||||||||||||||||||
| Equity investment impairment | |||||||||||||||||||||||
| Other income, net | ( | ( | ( | ||||||||||||||||||||
| Other expense, net | $ | $ | $ | $ | |||||||||||||||||||
9. SEGMENT INFORMATION
Our business is organized and operated in two
•The Materials Solutions segment, or MS, provides materials-based solutions, such as chemical vapor and atomic layer deposition materials, chemical mechanical planarization (“CMP”) slurries and pads, ion implantation specialty gases, formulated etch and clean materials, and other specialty materials that enable our customers to achieve better device performance and faster time to yield, while providing for lower total cost of ownership.
•The Advanced Purity Solutions segment, or APS, offers filtration, purification and contamination-control solutions that improve customers’ yield, device reliability and cost by ensuring the purity of critical liquid chemistries and gases and the cleanliness of wafers and other substrates used throughout semiconductor manufacturing processes, the semiconductor ecosystem and other high-technology industries.
The Company’s method for measuring profitability on a reportable segment basis is segment profit. Segment profit is defined as net sales less direct and indirect segment operating expenses, including certain general and administrative costs for the Company’s human resources, finance and information technology functions. The Company accounts for inter-segment sales and transfers as if the sales or transfers were to third parties. Inter-segment sales are presented as an elimination below. The remaining unallocated expenses consist mainly of the Company’s corporate functions as well as interest expense, interest income, amortization of intangible assets and income tax expense.
The Company’s chief operating decision maker (“CODM”) is the President and Chief Executive Officer. For each of the reportable segments, the CODM uses segment profit (based on each segment’s target model) for determining the allocation of resources (including employees, financial, or capital resources) to the segments to achieve the Company’s strategic plan and to assess the performance of each segment by monitoring actual results against performance targets established in the Company’s annual budget and forecasting process. Total assets by segment are not presented as that information is not used to allocate resources or assess performance at the segment level and is not regularly reviewed by the Company’s CODM.
Summarized financial information for the Company’s reportable segments is shown in the following tables for the three and nine months ended September 26, 2026 and September 27, 2025:
| Three months ended | |||||||||||||||||||||||
| September 26, 2026 | |||||||||||||||||||||||
| (In millions) | MS | APS | Inter-segment | Total | |||||||||||||||||||
| Net sales | $ | $ | $ | ( | $ | ||||||||||||||||||
| Cost of sales | ( | ||||||||||||||||||||||
| Operating expenses | |||||||||||||||||||||||
| Segment profit | $ | $ | $ | $ | |||||||||||||||||||
17
| Three months ended | |||||||||||||||||||||||
| September 27, 2025 | |||||||||||||||||||||||
| (In millions) | MS | APS | Inter-segment | Total | |||||||||||||||||||
| Net sales | $ | $ | $ | ( | $ | ||||||||||||||||||
| Cost of sales | ( | ||||||||||||||||||||||
| Operating expenses | |||||||||||||||||||||||
| Segment profit | $ | $ | $ | $ | |||||||||||||||||||
| Nine months ended | |||||||||||||||||||||||||||||
| September 26, 2026 | |||||||||||||||||||||||||||||
| (In millions) | MS | APS | Inter-segment | Total | |||||||||||||||||||||||||
| Net sales | $ | $ | $ | ( | $ | ||||||||||||||||||||||||
| Cost of sales | ( | ||||||||||||||||||||||||||||
| Operating expenses | |||||||||||||||||||||||||||||
| Segment profit | $ | $ | $ | $ | |||||||||||||||||||||||||
| Nine months ended | |||||||||||||||||||||||
| September 27, 2025 | |||||||||||||||||||||||
| (In millions) | MS | APS | Inter-segment | Total | |||||||||||||||||||
| Net sales | $ | $ | $ | ( | $ | ||||||||||||||||||
| Cost of sales | ( | ||||||||||||||||||||||
| Operating expenses | |||||||||||||||||||||||
| Segment profit | $ | $ | $ | $ | |||||||||||||||||||
The following table reconciles total segment profit to income before income tax expense for the three and nine months ended September 26, 2026 and September 27, 2025:
| Three months ended | Nine months ended | ||||||||||||||||||||||
| (In millions) | September 26, 2026 | September 27, 2025 | September 26, 2026 | September 27, 2025 | |||||||||||||||||||
| Total segment profit | $ | $ | $ | ||||||||||||||||||||
| Less: | |||||||||||||||||||||||
| Amortization of intangible assets | |||||||||||||||||||||||
| Unallocated general and administrative expenses | |||||||||||||||||||||||
| Operating income | |||||||||||||||||||||||
| Interest expense | |||||||||||||||||||||||
| Interest income | ( | ( | ( | ( | |||||||||||||||||||
| Other expense, net | |||||||||||||||||||||||
| Income before income tax expense | $ | $ | $ | $ | |||||||||||||||||||
The following table summarizes depreciation for the Company’s reportable segments for the three and nine months ended September 26, 2026 and September 27, 2025:
| Three months ended | Nine months ended | ||||||||||||||||||||||
| (In millions) | September 26, 2026 | September 27, 2025 | September 26, 2026 | September 27, 2025 | |||||||||||||||||||
| Depreciation: | |||||||||||||||||||||||
| MS | $ | $ | $ | $ | |||||||||||||||||||
| APS | |||||||||||||||||||||||
| Total depreciation | $ | $ | $ | $ | |||||||||||||||||||
18
In the following tables, net sales are disaggregated by customers’ country or region based on the ship to location of the customer for the three and nine months ended September 26, 2026 and September 27, 2025, respectively.
| Three months ended September 26, 2026 | |||||||||||||||||||||||
| (In millions) | MS | APS | Inter-segment | Total | |||||||||||||||||||
| North America | $ | $ | $ | ( | $ | ||||||||||||||||||
| Taiwan | |||||||||||||||||||||||
| China | |||||||||||||||||||||||
| South Korea | |||||||||||||||||||||||
| Japan | |||||||||||||||||||||||
| Europe | |||||||||||||||||||||||
| Southeast Asia | |||||||||||||||||||||||
| $ | $ | $ | ( | $ | |||||||||||||||||||
| Three months ended September 27, 2025 | |||||||||||||||||||||||
| (In millions) | MS | APS | Inter-segment | Total | |||||||||||||||||||
| North America | $ | $ | $ | ( | $ | ||||||||||||||||||
| Taiwan | |||||||||||||||||||||||
| China | |||||||||||||||||||||||
| South Korea | |||||||||||||||||||||||
| Japan | |||||||||||||||||||||||
| Europe | |||||||||||||||||||||||
| Southeast Asia | |||||||||||||||||||||||
| $ | $ | $ | ( | $ | |||||||||||||||||||
| Nine months ended September 26, 2026 | |||||||||||||||||||||||
| (In millions) | MS | APS | Inter-segment | Total | |||||||||||||||||||
| North America | $ | $ | $ | ( | $ | ||||||||||||||||||
| Taiwan | |||||||||||||||||||||||
| China | |||||||||||||||||||||||
| South Korea | |||||||||||||||||||||||
| Japan | |||||||||||||||||||||||
| Europe | |||||||||||||||||||||||
| Southeast Asia | |||||||||||||||||||||||
| $ | $ | $ | ( | $ | |||||||||||||||||||
| Nine months ended September 27, 2025 | |||||||||||||||||||||||
| (In millions) | MS | APS | Inter-segment | Total | |||||||||||||||||||
| North America | $ | $ | $ | ( | $ | ||||||||||||||||||
| Taiwan | |||||||||||||||||||||||
| China | |||||||||||||||||||||||
| South Korea | |||||||||||||||||||||||
| Japan | |||||||||||||||||||||||
| Europe | |||||||||||||||||||||||
| Southeast Asia | |||||||||||||||||||||||
| $ | $ | $ | ( | $ | |||||||||||||||||||
19
10. RESTRUCTURING COSTS
During 2025 and 2026, the Company initiated certain business restructuring activities aimed at improving operational efficiency and aligning resources with strategic priorities. These activities resulted in restructuring charges primarily related to (i) an internal reorganization, combining two complementary divisions into one and realigning our customer-facing organization, which occurred in the fourth quarter of 2024, (ii) commencing in the second quarter of 2025, workforce reductions and the abandonment of certain capital equipment no longer necessary for the Company’s long-term objectives, and (iii) actions that occurred in the second quarter of 2026 associated with the planned wind-down of the Company’s Life Sciences Fluid Management business, which includes the then-planned closure of a manufacturing facility. These restructuring activities are deemed to be discrete initiatives that are different from the Company’s ongoing productivity improvements.
The charges related to these restructuring activities were recognized in the condensed consolidated statements of operations for the three and nine months ended September 26, 2026 and September 27, 2025 and were as follows:
| Three months ended September 26, 2026 | Three months ended September 27, 2025 | ||||||||||||||||||||||||||||||||||
| (In millions) | Employee Termination Benefits | Asset Impairment Charges | Total | Employee Termination Benefits | Asset Impairment Charges | Total | |||||||||||||||||||||||||||||
| $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
| Nine months ended September 26, 2026 | Nine months ended September 27, 2025 | ||||||||||||||||||||||||||||||||||
| (In millions) | Employee Termination Benefits | Asset Impairment Charges | Total | Employee Termination Benefits | Asset Impairment Charges | Total | |||||||||||||||||||||||||||||
| $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Restructuring charges by reportable segment as well as unallocated corporate level charges for the three and nine months ended September 26, 2026 and September 27, 2025 were as follows:
| Three months ended September 26, 2026 | Three months ended September 27, 2025 | ||||||||||||||||||||||||||||||||||
| (In millions) | Employee Termination Benefits | Asset Impairment Charges | Total | Employee Termination Benefits | Asset Impairment Charges | Total | |||||||||||||||||||||||||||||
| MS | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
| APS | |||||||||||||||||||||||||||||||||||
| Unallocated corporate | ( | ( | |||||||||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
20
| Nine months ended September 26, 2026 | Nine months ended September 27, 2025 | ||||||||||||||||||||||||||||||||||
| (In millions) | Employee Termination Benefits | Asset Impairment Charges | Total | Employee Termination Benefits | Asset Impairment Charges | Total | |||||||||||||||||||||||||||||
| MS | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
| APS | |||||||||||||||||||||||||||||||||||
| Unallocated corporate | |||||||||||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
11. SUBSEQUENT EVENTS
Dividend
On October 14, 2026, the Company’s board of directors declared a quarterly cash dividend of $0.10 per share to be paid on November 18, 2026, to shareholders of record on the close of business on October 28, 2026.
21
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of the Company’s condensed consolidated financial condition and results of operation should be read along with the condensed consolidated financial statements and the accompanying notes thereto included elsewhere in this Quarterly Report on Form 10-Q (this “Quarterly Report”). The information, except for historical information, contained in this discussion and analysis or set forth elsewhere in this Quarterly Report includes forward-looking statements that involve risks and uncertainties. You should review Part II, Item 1A “Risk Factors” in this Quarterly Report and Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025 (the “Annual Report”) as well as our other U.S. Securities and Exchange Commission (“SEC”) filings for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis or set forth elsewhere in this Quarterly Report. These forward-looking statements are made only as of the date hereof, and, except as legally required, the Company assumes no obligation to publicly release the results of any revisions or updates to these forward-looking statements to reflect future events, unanticipated occurrences or otherwise.
Overview
The Company is a leading supplier of critical advanced materials and process solutions for the semiconductor and other high-technology industries. We leverage our unique breadth of capabilities to help our customers improve their productivity, product performance and technology in the most advanced manufacturing environments.
Our business is organized and operated in two operating segments.
•The Materials Solutions segment, or MS, provides materials-based solutions, such as chemical vapor and atomic layer deposition materials, chemical mechanical planarization (“CMP”) slurries and pads, ion implantation specialty gases, formulated etch and clean materials, and other specialty materials that enable our customers to achieve better device performance and faster time to yield, while providing for lower total cost of ownership.
•The Advanced Purity Solutions segment, or APS, offers filtration, purification and contamination-control solutions that improve customers’ yield, device reliability and cost by ensuring the purity of critical liquid chemistries and gases and the cleanliness of wafers and other substrates used throughout semiconductor manufacturing processes, the semiconductor ecosystem and other high-technology industries.
With our complementary capabilities, we believe we are uniquely positioned to create new, co-optimized and increasingly integrated solutions for our customers, which are designed to translate into improved device performance, lower cost of ownership and faster time to market. For example, we have the capabilities and core competencies to develop and co-optimize offerings solving customers’ complex manufacturing challenges across the deposition, CMP process and post-CMP modules, with solutions including advanced deposition materials, CMP slurries, pads and post-CMP cleaning chemistries (each from our MS segment), and CMP slurry filters, high-purity packaging and fluid monitoring systems (each from our APS segment).
The Company’s fiscal year is the calendar period ending each December 31. The Company’s fiscal quarters consist of 13-week or 14-week periods that end on a Saturday. The Company’s fiscal quarters in 2026 end on March 28, 2026, June 27, 2026, September 26, 2026 and December 31, 2026.
Global Trade Environment
Recent and continuing developments in U.S. and foreign trade policy have heightened global trade tensions and created significant uncertainty in macroeconomic and geopolitical environments, particularly with respect to China. Beginning in 2025, the U.S. government imposed tariffs and other trade measures affecting products and materials imported into the U.S., prompting protectionist and retaliatory actions by other countries. The U.S. government has initiated, and in certain cases, concluded investigations that have led, or may lead, to additional tariffs under Section 301 of the Trade Act of 1974, as amended, covering a broad range of products and trading partners, including countries in which we operate. The U.S. government has also imposed sector-specific tariffs, including on certain semiconductors, and has indicated that broader tariffs on semiconductors and related products may follow. If new tariffs are imposed by the U.S., other countries, including countries into which we sell, may once again impose protectionist and retaliatory measures. Certain arrangements between the U.S. and China that reduced tariffs and suspended certain export controls are temporary, and their expiration or non-renewal could result in higher tariffs or new restrictions affecting our products and supply chain. The U.S. tariff framework remains subject to ongoing litigation, legislative action, and potential additional executive action, any of which could materially alter the tariff rates applicable to our products and supply chain.
22
Because of the global nature of our business, these trade developments have exposed, and may continue to expose, our business and operations to various risks, particularly supply chain-related risks. The imposition of tariffs and other trade measures (i) has increased, and may continue to increase, our sourcing and manufacturing costs, (ii) has required, and may continue to require, us to adjust our supply chain and find alternative suppliers, (iii) may result in manufacturing and delivery delays and (iv) has increased, and may continue to increase, our compliance obligations and related costs. In addition, foreign governments may apply rules of origin or other trade measures that treat products we manufacture outside the United States as U.S.-origin goods, potentially subjecting those products to retaliatory tariffs or other restrictions that increase costs for our customers and reduce demand for our products in those markets. Foreign governments have also imposed, and may further impose, export controls or licensing requirements on raw materials and inputs on which we rely, which could disrupt our supply chain or increase our costs. As a result, we may face a reduction in the demand for, and in the competitiveness of, our products, including from increased local or domestically sourced competition, harm to our relationships with our customers, and decreased profitability. These risks may be exacerbated by the overall macroeconomic uncertainty stemming from current trade tensions which may slow economic growth and negatively impact the demand for products containing semiconductors, thereby decreasing the demand for our products.
Our strategy has been, and will continue to be, to build a resilient supply chain and a global manufacturing footprint near our customers. While this strategy is intended to mitigate the financial and operational impact of these trade policies, our business has been, and we expect it will be continue to be, impacted, particularly in the near term, by elevated tariffs imposed on our products. Certain tariffs are not eligible for duty drawback or preferential treatment under free trade agreements, which may limit the options available to us to mitigate their impact. Given the dynamic nature of this situation, the direct and indirect impact to our customers and our business is difficult to quantify; however, we will continue to closely monitor this evolving situation, further leverage our global footprint and regional supply chain, and explore additional options to mitigate trade-related risks.
Impact of Conflicts in the Middle East
The ongoing military conflict in the Middle East involving the U.S., Israel, Iran and other countries has caused uncertainty and volatility in the global markets, including, but not limited to, disruptions to shipping routes, oil and natural gas shortages, energy price fluctuations and availability of certain raw materials used in the production of our products. Revenue relating to products manufactured from raw materials or components sourced from or through this region does not constitute a material portion of our business and historically, we have not derived significant revenue from the region; however, as part of our commitment to the uninterrupted supply and uncompromised quality of our products, we have proactively implemented mitigation measures to manage the situation, including securing additional materials and building inventory, evaluating and activating established business continuity plans, and implementing prioritization measures in order to ensure operational stability. We will continue to closely monitor the situation and evaluate (and, as necessary, implement) additional mitigation measures.
Recent Events
Change in Useful Lives
In January 2026, we completed an assessment of the useful lives of our property, plant and equipment and adjusted the estimated useful lives of certain property, plant and equipment to more closely reflect the expected economic lives of these assets. These adjustments followed an analysis of our actual usage of assets, including the technological and physical obsolescence of these assets, our ability to continue to use equipment, historical usage trends, and anticipated capital plans and technology roadmaps, as well as industry trends and practices. Based on this analysis, we determined that the increase in useful lives was warranted and consistent with the Company’s historical and anticipated use of these assets. The updated estimated useful lives of certain assets for financial reporting purposes are as follows: buildings and improvements, 5 to 35 years increased to 12 to 40 years; manufacturing equipment, 5 to 10 years increased to 14 years; canisters and cylinders 3 to 12 years increased to 3 to 19 years; molds 3 to 5 years increased to 9 years and lab equipment, 3 to 8 years increased to 9 years.
This change in accounting estimate is effective beginning in fiscal year 2026 and is applied prospectively to the assets on our balance sheet as of December 31, 2025 and to future asset purchases. Based on the carrying amount of the assets included in property, plant and equipment, net in our condensed consolidated balance sheet as of December 31, 2025, we expect total depreciation expense in 2026 to be reduced by approximately $73.0 million, with the reduction recognized primarily in cost of sales and R&D expenses. For further discussion of the change, see Note 1 to the condensed consolidated financial statements.
23
Amended Revolving Credit Facility
On April 29, 2026, the Company amended the Revolving Credit Facility to provide for, among other things, lending commitments in an aggregate principal amount of up to $750.0 million, up from $575.0 million, and to extend the maturity to April 29, 2031 from July 6, 2027.
Critical Accounting Policies and Estimates
Management’s Discussion and Analysis of Financial Condition and Results of Operations is based upon the Company’s condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these condensed consolidated financial statements requires the Company to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, sales and expenses and related disclosure of contingent assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions.
The critical accounting policies affected most significantly by estimates, assumptions and judgments used in the preparation of the Company’s condensed consolidated financial statements are described in Part II, Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report. On an ongoing basis, the Company evaluates the critical accounting policies used to prepare its condensed consolidated financial statements, including, but not limited to, those related to business acquisitions. There have been no material changes in these critical accounting policies and estimates, except for the change in the estimated useful lives of certain property, plant and equipment. See Note 1 to the condensed consolidated financial statements for further discussion of the change.
Three and Nine Months Ended September 26, 2026 Compared to Three and Nine Months Ended September 27, 2025
The following table compares operating results for the three and nine months ended September 26, 2026 and September 27, 2025, both in dollars and as a percentage of net sales, for each caption.
| Three months ended | Nine months ended | |||||||||||||||||||||||||||||||||||||||||||||||||
| (Dollars in millions) | September 26, 2026 | September 27, 2025 | September 26, 2026 | September 27, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||
| Net sales | $ | 1,005.7 | 100.0 | % | $ | 807.1 | 100.0 | % | $ | 2,700.8 | 100.0 | % | $ | 2,372.7 | 100.0 | % | ||||||||||||||||||||||||||||||||||
| Cost of sales | 505.5 | 50.3 | 455.8 | 56.5 | 1,399.8 | 51.8 | 1,313.4 | 55.4 | ||||||||||||||||||||||||||||||||||||||||||
| Gross profit | 500.2 | 49.7 | 351.3 | 43.5 | 1,301.0 | 48.2 | 1,059.3 | 44.6 | ||||||||||||||||||||||||||||||||||||||||||
| Selling, general and administrative expenses | 136.5 | 13.6 | 101.8 | 12.6 | 380.6 | 14.1 | 320.2 | 13.5 | ||||||||||||||||||||||||||||||||||||||||||
| Engineering, research and development expenses | 87.5 | 8.7 | 80.9 | 10.0 | 245.6 | 9.1 | 250.0 | 10.5 | ||||||||||||||||||||||||||||||||||||||||||
| Amortization of intangible assets | 45.6 | 4.5 | 46.0 | 5.7 | 138.0 | 5.1 | 138.1 | 5.8 | ||||||||||||||||||||||||||||||||||||||||||
| Operating income | 230.6 | 22.9 | 122.6 | 15.2 | 536.8 | 19.9 | 351.0 | 14.8 | ||||||||||||||||||||||||||||||||||||||||||
| Interest expense | 45.4 | 4.5 | 47.9 | 5.9 | 142.9 | 5.3 | 151.3 | 6.4 | ||||||||||||||||||||||||||||||||||||||||||
| Interest income | (1.5) | (0.1) | (1.8) | (0.2) | (5.3) | (0.2) | (5.1) | (0.2) | ||||||||||||||||||||||||||||||||||||||||||
| Other expense, net | 0.2 | — | 4.2 | 0.5 | 9.4 | 0.3 | 5.3 | 0.2 | ||||||||||||||||||||||||||||||||||||||||||
| Income before income tax expense | 186.5 | 18.5 | 72.3 | 9.0 | 389.8 | 14.4 | 199.5 | 8.4 | ||||||||||||||||||||||||||||||||||||||||||
| Income tax expense | 28.7 | 2.9 | 1.5 | 0.2 | 46.2 | 1.7 | 12.5 | 0.5 | ||||||||||||||||||||||||||||||||||||||||||
| Equity in net loss of affiliates | — | — | 0.3 | — | 0.2 | — | 0.8 | — | ||||||||||||||||||||||||||||||||||||||||||
| Net income | $ | 157.8 | 15.7 | % | $ | 70.5 | 8.7 | % | $ | 343.4 | 12.7 | % | $ | 186.2 | 7.8 | % | ||||||||||||||||||||||||||||||||||
Net sales For the three months ended September 26, 2026, net sales increased by 24.6% to $1,005.7 million, compared to $807.1 million for the three months ended September 27, 2025. An analysis of the factors underlying the change in net sales is presented in the following table:
24
| (In millions) | |||||
Net sales in the three months ended September 27, 2025 | $ | 807.1 | |||
| Increase primarily associated with volume | 205.8 | ||||
| Decrease associated with effect of foreign currency translation | (7.2) | ||||
Net sales in the three months ended September 26, 2026 | $ | 1,005.7 | |||
As described in the table above, the increase in net sales was primarily attributable to a $205.8 million increase in net sales driven primarily by higher demand across both reporting segments, particularly for products supporting advanced logic and memory semiconductor production and the fabs being built to manufacture them, partially offset by a decrease of $7.2 million of sales attributable to unfavorable foreign currency translations, mainly due to the weakening of the Japanese yen relative to the U.S. dollar, compared to the fiscal quarter ended September 27, 2025.
On a geographic basis, sales percentage by customers’ country or region for the three months ended September 26, 2026 and September 27, 2025 and the percentage increase (decrease) in net sales for the three months ended September 26, 2026 compared to net sales for the three months ended September 27, 2025 were as follows:
| Three months ended | |||||||||||||||||
| September 26, 2026 | September 27, 2025 | Percentage increase (decrease) in sales | |||||||||||||||
| North America | 17 | % | 17 | % | 22 | % | |||||||||||
| Taiwan | 26 | % | 23 | % | 41 | % | |||||||||||
| China | 18 | % | 22 | % | — | % | |||||||||||
| South Korea | 13 | % | 14 | % | 23 | % | |||||||||||
| Japan | 10 | % | 10 | % | 29 | % | |||||||||||
| Europe | 7 | % | 7 | % | 21 | % | |||||||||||
| Southeast Asia | 9 | % | 8 | % | 51 | % | |||||||||||
Sales increased year over year in all disclosed geographic regions as a result of stronger demand for our products, particularly for products supporting the advanced nodes, except in China, where sales were flat compared with the prior-year period.
Net sales for the nine months ended September 26, 2026 increased by 13.8% to $2,700.8 million, compared to $2,372.7 million for the nine months ended September 27, 2025. An analysis of the factors underlying the change in net sales is presented in the following table:
| (In millions) | |||||
Net sales in the nine months ended September 27, 2025 | $ | 2,372.7 | |||
| Increase primarily associated with volume | 341.2 | ||||
| Decrease associated with effect of foreign currency translation | (13.1) | ||||
Net sales in the nine months ended September 26, 2026 | $ | 2,700.8 | |||
As described in the table above, the increase in net sales was primarily attributable to a $341.2 million increase in net sales driven primarily by higher demand across both reporting segments, partially offset by a decrease of $13.1 million of sales attributable to unfavorable foreign currency translations, mainly due to the weakening of the Japanese yen relative to the U.S. dollar, compared to the nine months ended September 27, 2025.
On a geographic basis, sales percentage by customers’ country or region for the nine months ended September 26, 2026 and September 27, 2025 and the percentage increase (decrease) in net sales for the nine months ended September 26, 2026 compared to the net sales for the nine months ended September 27, 2025 were as follows:
25
| Nine months ended | |||||||||||||||||
| September 26, 2026 | September 27, 2025 | Percentage increase (decrease) in sales | |||||||||||||||
| North America | 17 | % | 18 | % | 6 | % | |||||||||||
| Taiwan | 26 | % | 23 | % | 29 | % | |||||||||||
| China | 18 | % | 21 | % | — | % | |||||||||||
| South Korea | 13 | % | 13 | % | 13 | % | |||||||||||
| Japan | 10 | % | 10 | % | 22 | % | |||||||||||
| Europe | 7 | % | 7 | % | 4 | % | |||||||||||
| Southeast Asia | 9 | % | 8 | % | 27 | % | |||||||||||
The increase in sales to customers in North America primarily relates to increased demand for APS products across the semiconductor ecosystem, while sales of MS products were relatively unchanged. The increase in sales to customers in Taiwan primarily relates to increased demand for both MS and APS products, particularly for products supporting the advanced nodes. Sales to customers in China were relatively unchanged compared to the prior-year period as increased demand for APS products was substantially offset by lower demand for MS products. The increase in sales to customers in South Korea, Japan and Southeast Asia primarily relates to increased demand for both MS and APS products, particularly for products supporting the advanced nodes. The increase in sales to customers in Europe primarily relates to increased demand for MS products.
Gross margin The following table sets forth gross margin (gross profit as a percentage of net sales):
| Three months ended | Nine months ended | ||||||||||||||||||||||||||||||||||
| September 26, 2026 | September 27, 2025 | Percentage point change | September 26, 2026 | September 27, 2025 | Percentage point change | ||||||||||||||||||||||||||||||
| Gross margin: | 49.7 | % | 43.5 | % | 6.2 | 48.2 | % | 44.6 | % | 3.6 | |||||||||||||||||||||||||
Gross margin increased by 6.2 percentage points for the three months ended September 26, 2026, compared to the same period in the prior year. Gross margin increased primarily as a result of increased production volumes enabled by strong operational performance across our manufacturing facilities, a decrease in depreciation expense due to the change in useful lives for specific property, plant and equipment and tariff refunds. See Note 1 to the condensed consolidated financial statements for further discussion of the change.
Gross margin increased by 3.6 percentage points for the nine months ended September 26, 2026, compared to the same period in the prior year. Gross margin increased primarily as a result of increased production volumes enabled by strong operational performance across our manufacturing facilities, a decrease in depreciation expense due to the change in useful lives for specific property, plant and equipment and tariff refunds. See Note 1 to the condensed consolidated financial statements for further discussion of the change.
Selling, general and administrative expenses Selling, general and administrative (“SG&A”) expenses were $136.5 million in the three months ended September 26, 2026, compared to $101.8 million in the year-ago period. The factors underlying the change in SG&A expenses are presented in the following table:
| (In millions) | |||||
Selling, general and administrative expenses in the fiscal quarter ended September 27, 2025 | $ | 101.8 | |||
| Employee costs, primarily related to variable compensation | 18.8 | ||||
| Professional services | 9.2 | ||||
Other increases, net | 6.7 | ||||
Selling, general and administrative expenses in the fiscal quarter ended September 26, 2026 | $ | 136.5 | |||
SG&A expenses were $380.6 million in the nine months ended September 26, 2026, compared to $320.2 million in the year-ago period. The factors underlying the change in SG&A expenses are presented in the following table:
26
| (In millions) | |||||
Selling, general and administrative expenses in the nine months ended September 27, 2025 | $ | 320.2 | |||
| Employee costs, primarily related to variable compensation | 37.5 | ||||
| Professional services | 14.8 | ||||
| Other increases, net | 8.1 | ||||
Selling, general and administrative expenses in the nine months ended September 26, 2026 | $ | 380.6 | |||
Engineering, research and development expenses The Company’s ER&D efforts focus on the support or extension of current product lines and the development of new products and manufacturing technologies. ER&D expenses were $87.5 million in the three months ended September 26, 2026 compared to $80.9 million in the year-ago period. The factors underlying ER&D expenses are presented in the following table:
| (In millions) | |||||
Engineering, research and development expenses in the fiscal quarter ended September 27, 2025 | $ | 80.9 | |||
| Employee costs, primarily related to variable compensation | 6.5 | ||||
| Project-related expenses | 2.1 | ||||
| Depreciation expense | (2.9) | ||||
| Other increases, net | 0.9 | ||||
Engineering, research and development expenses in the fiscal quarter ended September 26, 2026 | $ | 87.5 | |||
ER&D expenses were $245.6 million in the nine months ended September 26, 2026 compared to $250.0 million in the year-ago period. The factors underlying ER&D expenses are presented in the following table:
| (In millions) | |||||
Engineering, research and development expenses in the nine months ended September 27, 2025 | $ | 250.0 | |||
| Project-related expenses | (8.9) | ||||
| Depreciation expense | (8.1) | ||||
| Employee costs, primarily related to variable compensation | 9.3 | ||||
| Other increases, net | 3.3 | ||||
Engineering, research and development expenses in the nine months ended September 26, 2026 | $ | 245.6 | |||
Amortization of intangible assets Amortization of intangible assets was $45.6 million in the three months ended September 26, 2026, compared to $46.0 million for the three months ended September 27, 2025.
Amortization of intangible assets was $138.0 million in the nine months ended September 26, 2026, compared to $138.1 million for the nine months ended September 27, 2025.
Interest expense Interest expense includes interest associated with debt outstanding and the amortization of debt issuance costs and original issuance discounts associated with such borrowings. Interest expense was $45.4 million in the three months ended September 26, 2026, compared to $47.9 million in the three months ended September 27, 2025. The decrease primarily reflects lower interest expense related to lower average debt balances for the period due to repayments on the Company’s outstanding debt.
Interest expense was $142.9 million in the nine months ended September 26, 2026, compared to $151.3 million in the nine months ended September 27, 2025. The decrease primarily reflects lower interest expense related to lower average debt balances for the period due to repayments on the Company’s outstanding debt.
Other expense, net Other expense, net was $0.2 million in the three months ended September 26, 2026 and consisted mainly of a loss on extinguishment of debt of $1.7 million, partially offset by foreign currency transaction gains of $1.1 million. Other expense, net was $4.2 million in the three months ended September 27, 2025 and consisted mainly of foreign currency transaction losses of $2.5 million and a loss on extinguishment of debt of $1.7 million.
Other expense, net was $9.4 million in the nine months ended September 26, 2026 and consisted mainly of equity investment impairment of $6.7 million and a loss on extinguishment of debt of $3.9 million. Other expense, net was $5.3 million in the nine months ended September 27, 2025 and consisted mainly of foreign currency transaction losses of 4.5 million and a loss on extinguishment of debt of $1.7 million.
27
Income tax expense Income tax expense was $28.7 million in the three months ended September 26, 2026, compared to income tax expense of $1.5 million in the three months ended September 27, 2025. The Company’s effective income tax rate was 15.4% for the three months ended September 26, 2026, compared to 2.1% for the three months ended September 27, 2025 The effective tax rate for the quarter ended September 26, 2026 was higher primarily due to an increase in pre-tax book income in the quarter and the release of unrecognized tax benefits in the quarter ended September 27, 2025 that did not recur in the quarter ended September 26, 2026.
Pillar 2
The Organization for Economic Co-operation and Development (“OECD”) introduced Base Erosion and Profit Shifting (“BEPS”) Pillar 2 rules that impose a global minimum tax rate of 15%. Numerous countries have already enacted, or are expected to enact, legislation to implement the 15% minimum tax rate. We have evaluated the impact of this legislation based on Entegris’ current global landscape and do not believe it will have a material impact. We will continue to monitor the ongoing legislation throughout the year and evaluate any future potential impact on our consolidated financial statements and related disclosures.
The Organization for Economic Co-operation and Development (“OECD”) introduced Base Erosion and Profit Shifting (“BEPS”) Pillar 2 rules that impose a global minimum tax rate of 15%. Numerous countries have already enacted, or are expected to enact, legislation to implement the 15% minimum tax rate. We have evaluated the impact of this legislation based on Entegris’ current global landscape and do not believe it will have a material impact. We will continue to monitor the ongoing legislation throughout the year and evaluate any future potential impact on our consolidated financial statements and related disclosures.
One Big Beautiful Bill Act
The One Big Beautiful Bill Act (the “Act”) was enacted on July 4, 2025. In accordance with ASC 740-10, the Company accounted for the effects of the Act in the quarter ended September 27, 2025, which was the quarter of enactment. The key provisions of the Act impacting the Company’s financial statements include the modification of interest expense limitations under Section 163(j) and revisions to foreign-derived intangible income (FDII) and global intangible low-taxed income (GILTI).
Certain provisions of the Act are effective for tax years beginning after December 31, 2025, and therefore affects the current year financial results. The Company continues to evaluate the impact of the Act on the Company’s future tax positions.
Net income Due to the factors noted above, the Company recorded net income of $157.8 million, or $1.03 per diluted share, in the three months ended September 26, 2026, compared to net income of $70.5 million, or $0.46 per diluted share, in the three months ended September 27, 2025.
In the nine months ended September 26, 2026, the Company recorded net income of $343.4 million, or $2.24 per diluted share,
compared to net income of $186.2 million, or $1.22 per diluted share, in the nine months ended September 27, 2025.
Non-GAAP Financial Measures The Company’s condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). The Company also utilizes certain non-GAAP financial measures as a complement to financial measures provided in accordance with GAAP in order to better assess and reflect trends affecting the Company’s business and results of operations. See the section entitled “Non-GAAP Information” below for additional detail, including the definition of certain non-GAAP financial measures and the reconciliation of these non-GAAP measures to the Company’s GAAP measures.
The Company’s principal non-GAAP financial measures are Adjusted EBITDA and Adjusted Operating Income, together with related measures thereof, and Non-GAAP Earnings Per Share (“Non-GAAP EPS”).
The following table compares non-GAAP financial measures for the three and nine months ended September 26, 2026 and September 27, 2025, both in dollars and as a percentage of net sales, for each caption.
| Three months ended | Nine months ended | ||||||||||||||||||||||||||||||||||
| (In millions) | September 26, 2026 | September 27, 2025 | Percent Change | September 26, 2026 | September 27, 2025 | Percent Change | |||||||||||||||||||||||||||||
| Adjusted Operating Income | $ | 269.4 | $ | 170.3 | 58 | % | $ | 677.7 | $ | 506.5 | 34 | % | |||||||||||||||||||||||
| Adjusted Operating Margin - as a % of net sales | 26.8 | % | 21.1 | % | 25.1 | % | 21.3 | % | |||||||||||||||||||||||||||
| Adjusted EBITDA | $ | 303.3 | $ | 220.7 | 37 | % | $ | 780.1 | $ | 658.1 | 19 | % | |||||||||||||||||||||||
| Adjusted EBITDA - as a % of net sales | 30.2 | % | 27.3 | % | 28.9 | % | 27.7 | % | |||||||||||||||||||||||||||
| Non-GAAP EPS | $ | 1.23 | $ | 0.72 | 71 | % | $ | 3.03 | $ | 2.05 | 48 | % | |||||||||||||||||||||||
The increase in Adjusted Operating Income and Non-GAAP EPS for the three and nine months ended September 26, 2026 compared to the year-ago period is generally attributable to an increase in sales, operating leverage in our manufacturing
28
facilities and decrease in depreciation expense due to the change in useful lives of specific property, plant and equipment, partially offset by an increase in SG&A expenses, primarily related to variable compensation.
The increase in Adjusted EBITDA for the three and nine months ended September 26, 2026 compared to the year-ago period is generally attributable to an increase in sales, operating leverage in our manufacturing facilities, partially offset by an increase in SG&A expenses, primarily related to variable compensation.
Segment Analysis
The Company currently reports its financial performance based on two reporting segments. The following is a discussion of the results of operations of these two business segments. See Note 9 to the condensed consolidated financial statements for additional information on the Company’s two segments.
The following table presents selected net sales and segment profit data for the Company’s two reportable segments, along with unallocated general and administrative expenses, for the three and nine months ended September 26, 2026 and September 27, 2025.
| Three months ended | Nine months ended | |||||||||||||||||||||||||
| (In millions) | September 26, 2026 | September 27, 2025 | September 26, 2026 | September 27, 2025 | ||||||||||||||||||||||
Materials Solutions | ||||||||||||||||||||||||||
| Net sales | $ | 404.1 | $ | 348.6 | $ | 1,126.5 | $ | 1,044.9 | ||||||||||||||||||
| Segment profit | 84.3 | 65.2 | 237.9 | 212.7 | ||||||||||||||||||||||
| Advanced Purity Solutions | ||||||||||||||||||||||||||
| Net sales | $ | 604.9 | $ | 460.8 | $ | 1,583.1 | $ | 1,334.6 | ||||||||||||||||||
| Segment profit | 212.7 | 118.2 | 497.2 | 322.2 | ||||||||||||||||||||||
| Unallocated general and administrative expenses | $ | 20.8 | $ | 14.8 | $ | 60.3 | $ | 45.8 | ||||||||||||||||||
Materials Solutions (MS)
For the third fiscal quarter of 2026, MS net sales increased to $404.1 million, up 16% compared to $348.6 million in the comparable period last year. The sales increase was driven primarily by increased sales from advanced deposition materials, specialty materials, selective etch chemistries and CMP consumables. MS reported a segment profit of $84.3 million in the third fiscal quarter of 2026, up 29% from a $65.2 million segment profit in the year-ago period. The segment profit increase was primarily due to higher sales, lower depreciation expense as a result of changes in useful lives of specific property, plant and equipment and tariff refunds, partially offset by higher variable compensation costs associated with stronger business performance in 2026 as compared to 2025.
For the nine months ended September 26, 2026, MS net sales increased to $1,126.5 million, up 8% compared to $1,044.9 million in the comparable period last year. The sales increase was driven primarily by increased sales from advanced deposition materials, selective etch chemistries, specialty materials and CMP consumables. MS reported a segment profit of $237.9 million in the nine months ended September 26, 2026, up 12% from a $212.7 million segment profit in the year-ago period. The segment profit increase was primarily due to higher sales, lower depreciation expense as a result of changes in useful lives of specific property, plant and equipment and tariff refunds, partially offset by higher variable compensation costs associated with stronger business performance in 2026 as compared to 2025.
Advanced Purity Solutions (APS)
For the third fiscal quarter of 2026, APS net sales increased to $604.9 million, up 31% compared to $460.8 million in the comparable period last year. The sales increase was mainly due to increased sales from liquid and gas filtration and purification products, front-opening unified pods (“FOUPs”), and fluid management solutions. APS reported a segment profit of $212.7 million in the third fiscal quarter of 2026, up 80% from $118.2 million in the year-ago period. The segment profit increase was primarily due to higher gross profit related to an increase in sales, lower depreciation expense as a result of changes in useful lives of specific property, plant and equipment and tariffs, partially offset by higher variable compensation costs associated with stronger business performance in 2026 as compared to 2025.
For the nine months ended September 26, 2026, APS net sales increased to $1,583.1 million, up 19% compared to $1,334.6 million in the comparable period last year. The sales increase was mainly due to increased sales from liquid and gas filtration and purification products, FOUPs, and fluid management solutions. APS reported a segment profit of $497.2 million in the nine months ended September 26, 2026, up 54% from $322.2 million in the year-ago period. The segment profit increase was due to
29
higher gross profit related to an increase in sales, lower depreciation expense as a result of changes in useful lives of specific property, plant and equipment and tariffs, partially offset by higher variable compensation costs associated with stronger business performance in 2026 as compared to 2025.
Unallocated general and administrative expenses
Unallocated general and administrative expenses totaled $20.8 million in the third fiscal quarter of 2026, up 41% compared to $14.8 million in the comparable period last year. The $6.0 million increase is primarily due to higher professional fees primarily related to internal operational enhancement initiatives.
Unallocated general and administrative expenses totaled $60.3 million in the nine months ended September 26, 2026, up 32% compared to $45.8 million in the comparable period last year. The $14.5 million increase is primarily due to a $7.0 million increase in professional fees, primarily related to internal operational enhancement initiatives, and $5.7 million increase in employee costs, primarily associated with stronger business performance in 2026 as compared to 2025.
Liquidity and Capital Resources
We consider the following when assessing our liquidity and capital resources:
| (In millions) | September 26, 2026 | December 31, 2025 | |||||||||
| Cash and cash equivalents | $ | 356.5 | $ | 360.4 | |||||||
| Working capital | 1,198.6 | 1,149.6 | |||||||||
| Total debt, net of unamortized discount and debt issuance costs | 3,260.6 | 3,697.6 | |||||||||
The Company has historically financed its operations and capital requirements through cash flow from its operating activities, long-term debt, lease financing, revolving credit facility and borrowings under domestic and international short-term lines of credit.
Based on our analysis, we believe our existing balances of domestic cash and cash equivalents and our currently anticipated operating cash flows will be sufficient to meet our cash needs arising in the ordinary course of business for the next twelve months and for the longer term.
We may seek to take advantage of opportunities to raise additional capital through debt financing or through public or private sales of securities. If in the future our available liquidity is not sufficient to meet the Company’s operating and debt service obligations as they come due, management would need to pursue alternative arrangements through additional equity or debt financing in order to meet the Company’s cash requirements. There can be no assurance that any such financing would be available on commercially acceptable terms, or at all. As of September 26, 2026, we have not experienced difficulty accessing capital and credit markets, but future volatility in the capital and credit markets may increase costs associated with issuing debt instruments or affect our ability to access those markets. In addition, it is possible that our ability to access the capital and credit markets could be limited at a time when we would like, or need, to do so, which could have an adverse impact on our ability to refinance maturing debt and/or react to changing economic and business conditions.
In summary, our cash flows for each period were as follows:
| Nine months ended | |||||||||||
| (In millions) | September 26, 2026 | September 27, 2025 | |||||||||
| Net cash provided by operating activities | $ | 606.0 | $ | 503.4 | |||||||
| Net cash used in investing activities | (123.9) | (234.5) | |||||||||
| Net cash used in financing activities | (486.8) | (204.1) | |||||||||
| (Decrease) increase in cash and cash equivalents | (3.9) | 70.6 | |||||||||
Operating activities Cash provided by operating activities is net income adjusted for certain non-cash items and changes in assets and liabilities. Cash provided by operating activities totaled $606.0 million in the nine months ended September 26, 2026, compared to $503.4 million in the nine months ended September 27, 2025. This increase was driven by a $143.5 million increase in net income adjusted for non-cash reconciling items, partially offset by $40.9 million decrease in operating assets and liabilities.
Changes in operating assets and liabilities for the nine months ended September 26, 2026 were driven by changes in trade accounts receivable, inventories and accounts payable and accrued liabilities. The change in trade accounts receivable is primarily due to an increase in sales. The change in inventories was mainly due to an increase in business activity. The change
30
in accounts payable and accrued liabilities was primarily driven by the timing of payments to vendors and higher incentive compensation accrual.
Investing activities Cash flows used in investing activities totaled $123.9 million in the nine months ended September 26, 2026, compared to cash flows used in investing activities of $234.5 million in the nine months ended September 27, 2025. The decrease resulted primarily from a decrease in cash paid for acquisition of property, plant and equipment of $117.2 million.
Financing activities Cash used in financing activities totaled $486.8 million during the nine months ended September 26, 2026, compared to cash used in financing activities of $204.1 million during the nine months ended September 27, 2025. The increase was primarily due to increased net debt activity of $300.0 million compared to the prior period, partially offset by stock activity of $19.8 million.
Our total dividend payments were $46.2 million in the nine months ended September 26, 2026 compared to $45.7 million in the nine months ended September 27, 2025. We have paid a cash dividend in each fiscal quarter since the fourth fiscal quarter of 2017. On October 14, 2026, the Company’s board of directors declared a quarterly cash dividend of $0.10 per share to be paid on November 18, 2026, to shareholders of record on the close of business on October 28 2026.
Other Liquidity and Capital Resources Considerations
Debt
| (In millions) | September 26, 2026 | December 31, 2025 | |||||||||
| Term Loans B due 2029 | $ | — | $ | 450.0 | |||||||
Senior Secured Notes due 2029 at 4.75% | 1,600.0 | 1,600.0 | |||||||||
Senior Notes due 2030 at 5.95% | 895.0 | 895.0 | |||||||||
Senior Notes due 2029 at 3.630% | 400.0 | 400.0 | |||||||||
Senior Notes due 2028 at 4.380% | 400.0 | 400.0 | |||||||||
Revolving Credit Facility due 2031 (1) | — | — | |||||||||
| Total debt (par value) | $ | 3,295.0 | $ | 3,745.0 | |||||||
(1) Our senior secured revolving credit facility due 2031 (the “Revolving Credit Facility”) bears interest at a rate per annum equal to, at the Company’s option, either (i) SOFR plus an applicable margin of 1.25%, 1.5% or 1.75% or (ii) a base rate plus an applicable margin of 0.25%, 0.5% or 0.75%, in each case depending on the Company’s first lien net leverage ratio. As of September 26, 2026, the applicable margins were 1.25% and 0.25%, respectively.
During the three and nine months ended September 26, 2026, the Company borrowed and repaid zero and $65.0 million, respectively, under the Revolving Credit Facility. The Revolving Credit Facility has commitments of $750.0 million as of September 26, 2026. There were no borrowings outstanding under the Revolving Credit Facility as of September 26, 2026 and December 31, 2025.
On April 29, 2026, the Company amended the Revolving Credit Facility to provide for, among other things, lending commitments in an aggregate principal amount of up to $750.0 million, up from $575.0 million, and to extend the maturity to April 29, 2031 from July 6, 2027, and to revise the applicable interest rate margins, commitment fees and certain negative covenants.
During the three and nine months ended September 26, 2026, the Company repaid $200.0 million and $450.0 million, respectively, under the Term Loans B under our Term Loan Facility. As of September 26, 2026, all outstanding borrowings under the Term Loans B had been fully repaid.
We refer to the Term Loan Facility and the Revolving Credit Facility as the “Credit Facilities”. The credit agreements that govern the Credit Facilities are referred to collectively as the “Amended Credit Agreement”. The Amended Credit Agreement contains a maximum first lien net leverage ratio covenant of 5.20 to 1.00, which is tested only when utilization of the Revolving Facility exceeds a specified threshold. Through September 26, 2026, the Company was in compliance with the financial covenant under its debt arrangements.
The Company also has a line of credit with one bank that provides for borrowings in Japanese yen for the Company’s Japanese subsidiaries, equivalent in the aggregate to approximately $6.3 million. During the three and nine months ended September 26, 2026, there were no borrowings under this line of credit, and no balance was outstanding at September 26, 2026.
31
Cash and cash equivalents and cash requirements
| (In millions) | September 26, 2026 | December 31, 2025 | |||||||||
| U.S. | $ | 58.3 | $ | 52.4 | |||||||
| Non-U.S. | 298.2 | 308.0 | |||||||||
| Cash and cash equivalents | $ | 356.5 | $ | 360.4 | |||||||
Our cash and cash equivalents include cash on hand and highly liquid debt securities with original maturities of three months or less, which are valued at cost and approximate fair value. We utilize a variety of funding strategies in an effort to ensure that our worldwide cash is available in the locations in which it is needed. We have accrued taxes on any earnings that are not indefinitely reinvested.
Cash requirements
We have cash requirements to support working capital needs, capital expenditures, business acquisitions, contractual obligations, commitments, principal and interest payments on debt and other liquidity requirements associated with our operations. We generally intend to use available cash and funds generated from our operations to meet these cash requirements, but in the event that additional liquidity is required we may also borrow under our Revolving Credit Facility.
There were no material changes to the cash requirements described in our Annual Report that were outside the ordinary course of business, except for the principal repayments of our Term Loans B as noted above. As a result, the Company’s future cash requirements have decreased due to the elimination of the related principal and interest payments. The Company also expects lower interest expense in future periods as result of the repayments.
Recently adopted accounting pronouncements See Note 1 to the Company’s condensed consolidated financial statements for a discussion of recently adopted accounting pronouncements.
Recently issued accounting pronouncements See Note 1 to the Company’s condensed consolidated financial statements for a discussion of recently issued but not yet adopted accounting pronouncements.
Non-GAAP Information The Company’s condensed consolidated financial statements are prepared in conformity with GAAP.
The Company also utilizes certain non-GAAP financial measures as a complement to financial measures provided in accordance with GAAP in order to better assess and reflect trends affecting the Company’s business and results of operations. These non-GAAP financial measures include Adjusted EBITDA and Adjusted Operating Income, together with related measures thereof, and Non-GAAP EPS, as well as certain other supplemental non-GAAP financial measures included in the discussion of the Company’s financial results.
The non-GAAP financial measures exclude certain specific items (“Special Items”), including certain items related to mergers and acquisitions; divestitures; restructuring and severance charges; impairments of assets; refinancing; certain income tax items and other discrete adjustments related to non-recurring, unusual or unanticipated charges, expenses or gains. We evaluate Special Items on an individual basis. Our evaluation of whether to exclude a Special Item for purposes of determining our non-GAAP financial measures considers both the quantitative and qualitative aspects of the Special Item, including among other things (i) its nature, (ii) whether or not it relates to our ongoing business operations, and (iii) whether or not we expect it to occur as part of our normal business on a regular basis.
Adjusted EBITDA is defined by the Company as net income adjusted to exclude (1) equity in net loss of affiliates, (2) income tax expense, (3) interest expense, (4) interest income, (5) other expense (income), net, (6) depreciation, and (7) the impact of any Special Items. Adjusted Operating Income is defined by the Company as Adjusted EBITDA exclusive of the depreciation addback noted above. The Company also utilizes ratios of non-GAAP financial measures such as Adjusted EBITDA to Company net sales and Adjusted Operating Income to Company net sales (referred to as Adjusted EBITDA Margin and Adjusted Operating Margin, respectively).
Non-GAAP Net Income is defined by the Company as net income, adjusted to exclude the impact of any Special Items and the tax effect of the foregoing adjustments to net income, stated on a per share basis, divided by diluted weighted average shares outstanding. Non-GAAP EPS is defined as Non-GAAP Net Income divided by our diluted weighted-average shares outstanding.
The Company provides supplemental non-GAAP financial measures to help management and investors to better understand our business and believes these measures provide investors and analysts additional meaningful information for the assessment of the Company’s ongoing results. Management also uses these non-GAAP measures to assist in the evaluation of the performance of the Company’s business segments and to make operating decisions.
32
Management believes the Company’s non-GAAP measures help indicate the Company’s baseline performance before certain gains, losses or other charges that may not be indicative of the Company’s business or future outlook and offer a useful view of business performance in that the measures provide a more consistent means of comparing performance. The Company believes the non-GAAP measures aid investors’ overall understanding of the Company’s results by providing a higher degree of transparency for such items and providing a level of disclosure that will help investors understand how management plans, measures and evaluates the Company’s business performance. Management believes that the inclusion of non-GAAP measures provides greater consistency in its financial reporting and facilitates investors’ understanding of the Company’s historical operating trends by providing an additional basis for comparisons to prior periods.
Management uses Adjusted EBITDA and Adjusted Operating Income to assist it in evaluations of the Company’s operating performance by excluding items that management does not consider as relevant in the results of its ongoing operations. Internally, these non-GAAP measures are used by management for planning and forecasting purposes, including the preparation of internal budgets; for allocating resources to enhance financial performance; for evaluating the effectiveness of operational strategies; and for evaluating the Company’s capacity to fund capital expenditures, secure financing and expand our business.
In addition, and as a consequence of the importance of these non-GAAP financial measures in managing our business, the Company’s board of directors uses non-GAAP financial measures in the evaluation process to determine management compensation.
The Company believes that certain analysts and investors use Adjusted EBITDA, Adjusted Operating Income and Non-GAAP EPS as supplemental measures to evaluate the overall operating performance of firms in the Company’s industry. Additionally, lenders or potential lenders use Adjusted EBITDA measures to evaluate the Company’s creditworthiness.
The presentation of non-GAAP financial measures is not meant to be considered in isolation, as a substitute for, or superior to, financial measures or information provided in accordance with GAAP. Management strongly encourages investors to review the Company’s condensed consolidated financial statements in their entirety and to not rely on any single financial measure.
Management notes that the use of non-GAAP measures has limitations, including but not limited to:
First, non-GAAP financial measures are not standardized. Accordingly, the methodology used to produce the Company’s non-GAAP financial measures may differ notably from the methodology used by other companies and may not be directly comparable to non-GAAP measures reported by other companies.
Second, the Company’s non-GAAP financial measures exclude items such as amortization and depreciation that are recurring. Amortization of intangibles and depreciation have been, and will continue to be for the foreseeable future, a significant recurring expense with an impact upon the Company’s results of operations, notwithstanding the lack of immediate impact upon cash flows.
Third, there is no assurance that the Company will not have future charges for integration costs, restructuring activities, loss on extinguishment of debt or modifications, loss (gain) on sale of businesses, or similar items and, therefore, may need to record additional charges (or credits) associated with such items, including the tax effects thereon. The exclusion of these items in the Company’s non-GAAP measures should not be construed as an implication that these costs are unusual, infrequent or non-recurring.
Management considers these limitations by providing specific information regarding the GAAP amounts excluded from these non-GAAP financial measures and evaluating these non-GAAP financial measures together with their most directly comparable financial measures calculated in accordance with GAAP. The calculations of Adjusted EBITDA, Adjusted Operating Income, Non-GAAP Net Income and Non-GAAP EPS, and reconciliations between these financial measures and their most directly comparable GAAP equivalents, are presented below in the accompanying tables.
33
Reconciliation of GAAP Net Income to Adjusted Operating Income and Adjusted EBITDA
| Three months ended | Nine months ended | ||||||||||||||||||||||
| (In millions) | September 26, 2026 | September 27, 2025 | September 26, 2026 | September 27, 2025 | |||||||||||||||||||
| Net sales | $ | 1,005.7 | $ | 807.1 | $ | 2,700.8 | $ | 2,372.7 | |||||||||||||||
| Net income | $ | 157.8 | $ | 70.5 | $ | 343.4 | $ | 186.2 | |||||||||||||||
| Net income - as a % of net sales | 15.7 | % | 8.7 | % | 12.7 | % | 7.8 | % | |||||||||||||||
| Adjustments to net income: | |||||||||||||||||||||||
| Equity in net loss of affiliates | — | 0.3 | 0.2 | 0.8 | |||||||||||||||||||
| Income tax expense | 28.7 | 1.5 | 46.2 | 12.5 | |||||||||||||||||||
| Interest expense | 45.4 | 47.9 | 142.9 | 151.3 | |||||||||||||||||||
| Interest income | (1.5) | (1.8) | (5.3) | (5.1) | |||||||||||||||||||
| Other expense, net | 0.2 | 4.2 | 9.4 | 5.3 | |||||||||||||||||||
| GAAP – Operating income | 230.6 | 122.6 | 536.8 | 351.0 | |||||||||||||||||||
| Operating margin - as a % of net sales | 22.9 | % | 15.2 | % | 19.9 | % | 14.8 | % | |||||||||||||||
IEEPA tariff refunds (1) | (8.3) | — | (8.3) | — | |||||||||||||||||||
Restructuring costs (2) | 1.5 | 1.7 | 11.2 | 17.4 | |||||||||||||||||||
Amortization of intangible assets (3) | 45.6 | 46.0 | 138.0 | 138.1 | |||||||||||||||||||
| Adjusted Operating Income | 269.4 | 170.3 | 677.7 | 506.5 | |||||||||||||||||||
| Adjusted operating margin - as a % of net sales | 26.8 | % | 21.1 | % | 25.1 | % | 21.3 | % | |||||||||||||||
| Depreciation | 33.9 | 50.4 | 102.4 | 151.6 | |||||||||||||||||||
| Adjusted EBITDA | $ | 303.3 | $ | 220.7 | $ | 780.1 | $ | 658.1 | |||||||||||||||
| Adjusted EBITDA – as a % of net sales | 30.2 | % | 27.3 | % | 28.9 | % | 27.7 | % | |||||||||||||||
(1) In the three months ended September, 26, 2026, the Company received $8.3 million of refunds of International Emergency Economic Powers Act (IEEPA) tariffs that were recognized in cost of goods sold as incurred from April 2025 through February 2026 and were not excluded from the Company's non-GAAP results in those periods. The Company excluded the refunds from non-GAAP results because they represent a discrete, non-recurring, out-of-period recovery arising from a legal and regulatory development rather than ongoing operating performance.
(2) Restructuring charges resulting from discrete cost saving initiatives inclusive of employee termination benefit and asset impairment charges, primarily related to (i) an internal reorganization, combining two complementary divisions into one and realigning our customer-facing organization, (ii) workforce reductions and (iii) the planned wind-down of the Company’s Life Sciences Fluid Management business.
(3) Non-cash amortization expense associated with intangibles acquired in acquisitions.
34
Reconciliation of GAAP Net Income and Earnings per Share to Non-GAAP Net Income and EPS
| Three months ended | Nine months ended | ||||||||||||||||||||||
| (In millions, except per share data) | September 26, 2026 | September 27, 2025 | September 26, 2026 | September 27, 2025 | |||||||||||||||||||
| Net income | $ | 157.8 | $ | 70.5 | $ | 343.4 | $ | 186.2 | |||||||||||||||
| Adjustments to net income: | |||||||||||||||||||||||
IEEPA tariff refunds(1) | (8.3) | — | (8.3) | — | |||||||||||||||||||
Restructuring costs (2) | 1.5 | 1.7 | 11.2 | 17.4 | |||||||||||||||||||
Equity investment impairment(3) | — | — | 6.7 | — | |||||||||||||||||||
Loss on extinguishment of debt (4) | 1.7 | 1.7 | 3.9 | 1.7 | |||||||||||||||||||
Amortization of intangible assets (5) | 45.6 | 46.0 | 138.0 | 138.1 | |||||||||||||||||||
Tax effect of adjustments to net income and discrete tax items (6) | (8.6) | (10.0) | (30.0) | (31.4) | |||||||||||||||||||
| Non-GAAP Net Income | $ | 189.7 | $ | 109.9 | $ | 464.9 | $ | 312.0 | |||||||||||||||
| Diluted earnings per common share | $ | 1.03 | $ | 0.46 | $ | 2.24 | $ | 1.22 | |||||||||||||||
| Effect of adjustments to net income | 0.21 | 0.26 | 0.79 | 0.83 | |||||||||||||||||||
Diluted Non-GAAP EPS (7) | $ | 1.23 | $ | 0.72 | $ | 3.03 | $ | 2.05 | |||||||||||||||
| Diluted weighted average shares outstanding | 153.9 | 152.3 | 153.6 | 152.1 | |||||||||||||||||||
(1) In the three months ended September, 26, 2026, the Company received $8.3 million of refunds of International Emergency Economic Powers Act (IEEPA) tariffs that were recognized in cost of goods sold as incurred from April 2025 through February 2026 and were not excluded from the Company's non-GAAP results in those periods. The Company excluded the refunds from non-GAAP results because they represent a discrete, non-recurring, out-of-period recovery arising from a legal and regulatory development rather than ongoing operating performance.
(2) Restructuring charges resulting from discrete cost saving initiatives inclusive of employee termination benefit and asset impairment charges, primarily related to (i) an internal reorganization, combining two complementary divisions into one and realigning our customer-facing organization (ii) workforce reductions and (iii) the planned wind-down of the Company’s Life Sciences Fluid Management business.
(3) Equity impairment loss in 2026 that reduced our carrying basis to zero.
(4) Loss on extinguishment of debt of our Term Loan Facility in 2026.
(5) Non-cash amortization expense associated with intangibles acquired in acquisitions.
(6) The tax effect of pre-tax adjustments to net income was calculated using the applicable marginal tax rate for each respective year.
(7) As a result of displaying amounts in millions, the per-share components may not sum due to rounding.
35
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are exposed to financial market risks, including fluctuations in interest rate and foreign currency exchange rates. For information about our exposure to market risks, see Part II, Item 7A. “Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report. There have been no material changes to the Company’s market risk during the three months ended September 26, 2026.
Item 4. Controls and Procedures
(a) Evaluation of disclosure controls and procedures.
The Company’s management, including the Chief Executive Officer, or CEO, and Chief Financial Officer, or CFO, has conducted an evaluation of the effectiveness of the Company’s disclosure controls and procedures (as defined under Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934, or the Exchange Act) as of September 26, 2026. The term “disclosure controls and procedures” means controls and other procedures that are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on management’s evaluation (with the participation of the Company’s CEO and CFO), as of September 26, 2026, the Company’s CEO and CFO have concluded that the disclosure controls and procedures used by the Company were effective to provide reasonable assurance that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and is accumulated and communicated to management, including its principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.
(b) Changes in internal control over financial reporting.
There have been no changes in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) identified in connection with the foregoing evaluation of disclosure controls and procedures that occurred during the most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
36
PART II
OTHER INFORMATION
Item 1. Legal Proceedings
We are, from time to time, involved in various claims, proceedings and lawsuits relating to our business, employees, intellectual property and other matters arising in the ordinary course of business. The Company believes the final outcome of these matters will not have a material adverse effect on its condensed consolidated financial statements. The Company expenses legal costs as incurred.
Item 1A. Risk Factors
In addition to the other information set forth in this Quarterly Report, you should carefully consider the risk factors and other cautionary statements described in Part I, Item 1A. “Risk Factors” in our Annual Report, which could materially affect our business, financial condition or future results. There have been no material changes to the risk factors described in our Annual Report.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
None.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
Rule 10b5-1 Trading Plan Arrangements
During the fiscal quarter ended September 26, 2026, no director or officer, as defined in Rule 16a-1 under the Exchange Act, adopted terminated
37
Item 6. Exhibits
EXHIBIT INDEX
A.The Company hereby incorporates by reference as exhibits to this Quarterly Report on Form 10-Q the following documents:
| Reference | Document Incorporates | Referenced Document on file with the Commission | ||||||||||||
| 3.1 | Exhibit 3.1 to Entegris, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on May 8, 2026 | |||||||||||||
| 3.2 | Exhibit 3.2 to Entegris, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on May 8, 2026 | |||||||||||||
B.The Company hereby files as exhibits to this Quarterly Report on Form 10-Q the following documents:
| Exhibit No. | Document Filed Herewith | ||||||||||
| 31.1 | |||||||||||
| 31.2 | |||||||||||
| 32.1 | |||||||||||
101.INS | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | ||||||||||
101.SCH | XBRL Taxonomy Extension Schema Document | ||||||||||
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document | ||||||||||
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document | ||||||||||
101.LAB | XBRL Taxonomy Extension Label Linkbase Document | ||||||||||
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document | ||||||||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | ||||||||||
38
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| ENTEGRIS, INC. | ||||||||
Date: October 29, 2026 | /s/ Sukhi Nagesh | |||||||
| Sukhi Nagesh | ||||||||
| Senior Vice President and Chief Financial Officer | ||||||||
| (on behalf of the registrant and as | ||||||||
| principal financial officer) | ||||||||
39
Exhibit 31.1
CERTIFICATIONS
I, David Reeder, certify that:
1.I have reviewed this Report on Form 10-Q of Entegris, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects, the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Dated: October 29, 2026 | /s/ David Reeder | ||||
| David Reeder | |||||
| President and Chief Executive Officer | |||||
| (Principal Executive Officer) | |||||
Exhibit 31.2
CERTIFICATIONS
I, Sukhi Nagesh, certify that:
1.I have reviewed this Report on Form 10-Q of Entegris, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects, the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Dated: October 29, 2026 | /s/ Sukhi Nagesh | ||||
| Sukhi Nagesh | |||||
| Senior Vice President and Chief Financial Officer | |||||
| (Principal financial officer) | |||||
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q (the “Report”) of Entegris, Inc, a Delaware corporation (the “Company”), for the period ended September 26, 2026 as filed with the Securities and Exchange Commission on the date hereof, David Reeder, President and Chief Executive Officer of the Company, and Sukhi Nagesh, Senior Vice President and Chief Financial Officer of the Company, each hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:
(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: October 29, 2026 | /s/ David Reeder | ||||
| David Reeder | |||||
| President and Chief Executive Officer | |||||
| /s/ Sukhi Nagesh | |||||
| Sukhi Nagesh | |||||
| Senior Vice President and Chief Financial Officer | |||||